163 related articles for article (PubMed ID: 33287648)
21. Wnt targets genes are not differentially expressed in desmoid tumors bearing different activating β-catenin mutations.
Timbergen MJM; Janssen ML; Verhoef C; Grünhagen DJ; Chibon F; Smid M; Sleijfer S; Wiemer EAC
Eur J Surg Oncol; 2019 Apr; 45(4):691-698. PubMed ID: 30528042
[TBL] [Abstract][Full Text] [Related]
22. Blocking Wnt Secretion Reduces Growth of Hepatocellular Carcinoma Cell Lines Mostly Independent of β-Catenin Signaling.
Wang W; Xu L; Liu P; Jairam K; Yin Y; Chen K; Sprengers D; Peppelenbosch MP; Pan Q; Smits R
Neoplasia; 2016 Dec; 18(12):711-723. PubMed ID: 27851986
[TBL] [Abstract][Full Text] [Related]
23. The angiotensin type 2 receptor in the human adrenocortical zona glomerulosa and in aldosterone-producing adenoma: low expression and no functional role.
Vanderriele PE; Caroccia B; Seccia TM; Piazza M; Lenzini L; Torresan F; Iacobone M; Unger T; Rossi GP
Clin Sci (Lond); 2018 Mar; 132(6):627-640. PubMed ID: 29436482
[TBL] [Abstract][Full Text] [Related]
24. SALL4 promotes the tumorigenicity of cervical cancer cells through activation of the Wnt/β-catenin pathway via CTNNB1.
Chen M; Li L; Zheng PS
Cancer Sci; 2019 Sep; 110(9):2794-2805. PubMed ID: 31336010
[TBL] [Abstract][Full Text] [Related]
25. Knockout of CTNNB1 by CRISPR-Cas9 technology inhibits cell proliferation through the Wnt/β-catenin signaling pathway.
Guan L; Zhu S; Han Y; Yang C; Liu Y; Qiao L; Li X; Li H; Lin J
Biotechnol Lett; 2018 Mar; 40(3):501-508. PubMed ID: 29249062
[TBL] [Abstract][Full Text] [Related]
26. miRNA-203 Modulates Aldosterone Levels and Cell Proliferation by Targeting Wnt5a in Aldosterone-Producing Adenomas.
Peng KY; Chang HM; Lin YF; Chan CK; Chang CH; Chueh SJ; Yang SY; Huang KH; Lin YH; Wu VC; Wu KD
J Clin Endocrinol Metab; 2018 Oct; 103(10):3737-3747. PubMed ID: 30085132
[TBL] [Abstract][Full Text] [Related]
27. Double somatic mutations in
Nanba K; Blinder AR; Udager AM; Hirokawa Y; Miura T; Okuno H; Moriyoshi K; Yamazaki Y; Sasano H; Yasoda A; Satoh-Asahara N; Rainey WE; Tagami T
Front Endocrinol (Lausanne); 2024; 15():1286297. PubMed ID: 38505749
[TBL] [Abstract][Full Text] [Related]
28.
Yang E; Ding C; Zhu X; Zhang J; Zhang W; Zhao Y; Zhang J; Lin X
Cardiovasc Diagn Ther; 2023 Jun; 13(3):523-533. PubMed ID: 37405011
[TBL] [Abstract][Full Text] [Related]
29. CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression.
Yu J; Liu D; Sun X; Yang K; Yao J; Cheng C; Wang C; Zheng J
Cell Death Dis; 2019 Jan; 10(1):26. PubMed ID: 30631044
[TBL] [Abstract][Full Text] [Related]
30. The T cell factor/beta-catenin antagonist PKF115-584 inhibits proliferation of adrenocortical carcinoma cells.
Doghman M; Cazareth J; Lalli E
J Clin Endocrinol Metab; 2008 Aug; 93(8):3222-5. PubMed ID: 18544621
[TBL] [Abstract][Full Text] [Related]
31. Somatic and inherited mutations in primary aldosteronism.
Fernandes-Rosa FL; Boulkroun S; Zennaro MC
J Mol Endocrinol; 2017 Jul; 59(1):R47-R63. PubMed ID: 28400483
[TBL] [Abstract][Full Text] [Related]
32. EZH2 activates Wnt/β-catenin signaling in human uterine fibroids, which is inhibited by the natural compound methyl jasmonate.
Ali M; Stone D; Laknaur A; Yang Q; Al-Hendy A
F S Sci; 2023 Aug; 4(3):239-256. PubMed ID: 37182601
[TBL] [Abstract][Full Text] [Related]
33. Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib.
Lachenmayer A; Alsinet C; Savic R; Cabellos L; Toffanin S; Hoshida Y; Villanueva A; Minguez B; Newell P; Tsai HW; Barretina J; Thung S; Ward SC; Bruix J; Mazzaferro V; Schwartz M; Friedman SL; Llovet JM
Clin Cancer Res; 2012 Sep; 18(18):4997-5007. PubMed ID: 22811581
[TBL] [Abstract][Full Text] [Related]
34. MALAT1-Driven Inhibition of Wnt Signal Impedes Proliferation and Inflammation in Fibroblast-Like Synoviocytes Through CTNNB1 Promoter Methylation in Rheumatoid Arthritis.
Li GQ; Fang YX; Liu Y; Meng FR; Wu X; Zhang CW; Zhang Y; Liu D; Gao B
Hum Gene Ther; 2019 Aug; 30(8):1008-1022. PubMed ID: 30909750
[TBL] [Abstract][Full Text] [Related]
35. Zinc finger transcription factor 191, directly binding to β-catenin promoter, promotes cell proliferation of hepatocellular carcinoma.
Liu G; Jiang S; Wang C; Jiang W; Liu Z; Liu C; Saiyin H; Yang X; Shen S; Jiang D; Zhou P; Han D; Hu X; Yi Q; Yu L
Hepatology; 2012 Jun; 55(6):1830-9. PubMed ID: 22213192
[TBL] [Abstract][Full Text] [Related]
36. Nutlin-3a as a novel anticancer agent for adrenocortical carcinoma with CTNNB1 mutation.
Hui W; Liu S; Zheng J; Fang Z; Ding Q; Feng C
Cancer Med; 2018 Apr; 7(4):1440-1449. PubMed ID: 29532999
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological analysis of β-catenin and Axin-1 in solid pseudopapillary neoplasms of the pancreas.
Huang SC; Ng KF; Yeh TS; Chang HC; Su CY; Chen TC
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S438-46. PubMed ID: 21769465
[TBL] [Abstract][Full Text] [Related]
38. ERK1/2 MAPKs and Wnt signaling pathways are independently involved in adipocytokine-mediated aldosterone secretion.
Vleugels K; Schinner S; Krause D; Morawietz H; Bornstein SR; Ehrhart-Bornstein M; Krug AW
Exp Clin Endocrinol Diabetes; 2011 Nov; 119(10):644-8. PubMed ID: 21915818
[TBL] [Abstract][Full Text] [Related]
39. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
40. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.
Tissier F; Cavard C; Groussin L; Perlemoine K; Fumey G; Hagneré AM; René-Corail F; Jullian E; Gicquel C; Bertagna X; Vacher-Lavenu MC; Perret C; Bertherat J
Cancer Res; 2005 Sep; 65(17):7622-7. PubMed ID: 16140927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
